CA9 and breast cancer: The application of an antibody against the CAIX PG domain, but not against the CAIX catalytic domain, inhibited MCT transport activity and cell migration in hypoxic MDA-MB-231 and MCF-7 breast cancer cells, indicating that the MCT-CAIX transport metabolon might also play a role in cell migration [95].